Quality of life in endometrial cancer survivors

Maturitas

Volumn 31, Issue 3, 1999, Pages 227-236

  Li, Cairu ^a   Samsioe, Göran ^a   Iosif, Constantin ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endometrial cancer; Hormone replacement therapy; Quality of life

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NORMAL HUMAN; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL TIME;

AGED; CASE-CONTROL STUDIES; CLIMACTERIC; COUNSELING; EDUCATIONAL STATUS; ENDOMETRIAL NEOPLASMS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 0033028962     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00106-6     Document Type: Article

References (28)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1996. CA Cancer J Clin. 46:1996;5-27.
2. Cancer Incidence in Sweden 1994. 17 April, 1997;Center for Epidemiology.
3. Cancer Statistics Review 1973-1987. 1989;US Department of Health and Human Services, Bethesda, MA.
4. Bonnett A., Roder D., Esterman A. Epidemiology of Cancer in South Australia: Incidence, Mortality and Survival 1977 to 1989, Incidence and Mortality 1989, Analyzed by Type and Geographical Location. 1991;Adelaide, Lutheran Press.
5. Stebeck M., Rosén M., Holm L.E. Cancer Survival in Sweden, in 1961 - 1991. 1992;53-59 Scandinavian University Press.
6. Collins A. Psychosocial factors associated with mood change and symptoms during transition to menopause. Menopause. 4:1997;269.
7. Caicoya M., Rodriguez T. Stroke incidence in Austrurias, 1990-1991. Rev Neurol. 24(131):1996;806-811.
8. Scott F.W., David R.O., Frank D.S. et al. Trends in diabetes and diabetic complication, 1980-1987. Diabetes Care. 8:1992;960-967.
9. Fuster V., Ross R. Atherosclerosis and Coronary Artery Disease. 1996;13-16 Lippincott-Raven, Philadelphia.
10. Collins A., Landgren B.M. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas. 20:1995;101-111.
11. Michael P., Umbertto V. Oxford Text Book of Oncology. 1995;2408-2413 Oxford University Press, New York.
12. Klastersky J., Schimpff S.C., Senn H.J. Hand Book of Supportive Care in Cancer. 1995;232-234 Marcel Dekker, New York.
13. Marchioro G., Azzarello G., Checchin F. et al. The impact of a psychological intervention on quality of life in non-metastatic breast cancer. Eur J Cancer. 9:1996;1612-1615.
14. Burish T.G., Redd W.H. Symptom control in psychosocial oncology. Cancer. 74:1994;1438-1444.
15. Razavi D., Delvaux N. The psychiatrist's perspective on quality of life and quality of care in oncology: concepts, symptom management, communication issues. Eur J Cancer. 31A(Suppl 6):1995;25-29.
16. Limouzin Lamothe M.A., Mairon N., Joyce C.R., Le Gal M. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol. 170(2):1994;618-624.
17. Wiklund I., Holst J., Karlberg J. et al. A new methodological approach to the evaluation of quality of life in post menopausal women. Maturitas. 14:1992;211-224.
18. Birkhäuser M.H., Rozenbaum H. European Consensus Development Conference on Menopause. 1996;69-77 Editions ESKA.
19. Berek J.S., Adashi E.Y., Hillard P.A. Novak's Gynecology. 1996;1091-1092 Williams and Wilkins, Baltimore.
20. Creasmen W.T. Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol. 77(2):1991;308-312.
21. Wren B.G. Hormone therapy following breast and uterine cancer. Bailliere's Clin Endocrinol Metab. 7(1):1993;225-241.
22. Smith H.O., Kammerer-Doak D.N., Barbo D.M., Sarto G.E. Hormone replacement therapy in the menopause: a pro opinion. CA Cancer J Clin. 46:1996;343-363.
23. Burger C.W., Koomen I., Peters N.A., Van Leeuwen F.E., Kenemans P. Postmenopausal hormone replacement therapy and cancer of the female genital tract and the breast. Eur Menopause J. 4(1):1997;23-36.
24. Creasman W.T., Henderson D., Hinhaw W., Clarke Person D.L. Estrogen replacement therapy in the patients treated for endometrial cancer. Obstet Gynecol. 67:1986;326-330.
25. Lee R.B., Burke T.W., Park R.C. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 36:1990;189-191.
26. Bryant G.W. Administration of estrogen to patients with a previous diagnosis of endometrial adenocarcinoma. South Med J. 83:1990;725-726.
27. Chapman J.A., Disaia P.J., Osann K. et al. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol. 175:1996;1195-2000.
28. Ploch E. Hormonal replacement therapy in patients after cervical cancer treatment. Gynecol Oncol. 26:1987;169-177.